Thu, Mar 28, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Paper: High-testosterone hedge fund managers significantly underperform low-testosterone guys

Tuesday, January 23, 2018
Opalesque Industry Update - Yan Lu from the University of Central Florida-Department of Finance and Melvyn Teo, Singapore Management University - Lee Kong Chian School of Business, published a paper using facial width-to-height ratio (fWHR) as a proxy for pubertal testosterone and showing that high-testosterone hedge fund managers significantly underperform low-testosterone hedge fund managers after adjusting for risk.

The authors admit that testosterone positively correlates with a host of benefits. These benefits include improved search persistence in male chicks, alpha status in Capuchin monkeys, fearlessness in humans, higher military rank amongst officer cadets at West Point, executive leadership for firm CEOs, and stronger achievement drive in U.S. presidents. However, after their research the duo say they were able to show empirically that superior investment performance is not one of them.

"Using facial width-to-height ratio as a proxy for pubertal testosterone, we find that hedge funds operated by high-testosterone managers deliver substantially lower alphas, Sharpe ratios, and information ratios than do hedge funds operated by low-testosterone managers. In addition, masculine hedge fund managers take on greater operational risk which hurts investors. Funds operated by such managers are more likely to terminate early, report violations on their Form ADVs, and exhibit higher w-scores - a univariate measure of operational risk.

Buying lottery-like stocks and holding on to loser stocks

"Moreover, masculine managers are more likely to engage in suboptimal trading behavior such as purchasing lottery-like stocks and holding on to loser stocks. Interestingly, we find that fund investors are themselves affected by testosterone; high-testosterone fund investors running FoFs underperform low-testosterone fund investors running FoFs. Fund investors appear to invest in their own image. High-testosterone investors subscribe to hedge funds managed by high-testosterone managers while the low-testosterone investors gravitate toward hedge funds managed by low-testosterone managers.

"These results help us understand how masculine fund managers can raise capital despite underperforming their competitors and exhibiting greater operational risk. In the context of the ultra-competitive and male-dominated hedge fund industry, where masculine traits such as aggression, competitiveness, and drive, are encouraged, expected, and even celebrated, our results on the underperformance of high-testosterone fund managers are indeed surprising. They indicate that, contrary to what popular stereotypes of successful investment managers imply, testosterone can be inimical to investment management. Since alpha males do not deliver alpha, investors will do well to go against conventional wisdom and eschew masculine fund managers."

Opalesque Note: You can get to know Melvyn Teo via our video with him: www.opalesque.tv/hedge-fund-videos/Melvyn_Teo/index.php

Article source - Opalesque is not responsible for the content of external internet sites

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1